Welcome to our dedicated page for Dynatronics news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on Dynatronics stock.
Dynatronics Corp (DYNT) delivers innovative medical solutions through advanced rehabilitation equipment and therapeutic devices. This news hub provides investors and healthcare professionals with essential updates directly from the company, ensuring access to verified information about product developments and corporate milestones.
Track official announcements including new product releases, regulatory updates, and strategic partnerships. Our curated feed eliminates the need to monitor multiple sources, offering a centralized repository for earnings reports, leadership changes, and clinical trial progress related to DYNT's medical devices.
Discover updates spanning three key areas: product innovation in physical therapy equipment, distribution network expansions, and clinical support initiatives. Each update is vetted for relevance to investors assessing market position and medical professionals evaluating equipment solutions.
Bookmark this page for streamlined access to Dynatronics' latest developments. Combine regular checks with our news alerts to maintain current awareness of this medical device innovator's progress in rehabilitation technology and patient care solutions.
Dynatronics (NASDAQ: DYNT) announced its transition to the OTC Markets Group due to noncompliance with Nasdaq's minimum bid price requirement. The company received notice of impending delisting from Nasdaq effective July 9, 2024. Consequently, Dynatronics' common stock will be quoted on the OTCQB Venture Market immediately following the delisting. The ticker symbol and CUSIP will remain unchanged, and shareholders need not take any action. Despite the transition, Dynatronics will continue its business operations and remain a reporting company under the Securities Exchange Act of 1934.
Dynatronics , a leading manufacturer of athletic training, physical therapy, and rehabilitation products, reported financial results for its third quarter of fiscal year 2024. The CEO highlighted progress in sales goals and positive EBITDA. New product lines were introduced to enhance sales. Key financial results include total net sales of $7.7 million, a gross profit margin of 23.7%, and a net loss attributable to common stockholders of $0.9 million. The company provided guidance for fiscal year 2024, estimating net revenue to be $32.5 million to $34 million, with ongoing volatility expected due to economic challenges. Dynatronics will hold a conference call to review its third quarter results.
FAQ
What is the current stock price of Dynatronics (DYNT)?
What is the market cap of Dynatronics (DYNT)?
